The present invention provides a silymarin formulation comprises of synergistic combination of Gelucire 44/14 and Transcutol HP having high solubility, dissolution rate and bioavailability of silymarin and a process for preparing the same. The present invention also provides the use of said formulation manufacturing of pharmaceutical dosage form.